Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2015

01.08.2015 | Epidemiology

Socio-demographic, treatment-related, and health behavioral predictors of persistent pain 15 months and 7–9 years after surgery: a nationwide prospective study of women treated for primary breast cancer

verfasst von: M Johannsen, S Christensen, R Zachariae, AB Jensen

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to investigate and report prevalence and risk factors for persistent pain in breast cancer patients at 15 months and 7–9 years post surgery. A nationwide inception cohort study including 3343 women treated for primary breast cancer between 2001 and 2004, who returned a questionnaire 3 months post surgery. Socio-demographic and clinical information was obtained from registries. Questionnaire data on pain and health behaviors were obtained 15 months and 7–9 years post surgery. A total of 1905 women were eligible for analysis. At 15-month post surgery, 32.7 % reported pain “almost every day” or more frequently. At 7–9 years post surgery, the prevalence decreased to 20.4 %. Socio-demographic (young age, lower education, lower income, lower occupational status), treatment-related (being lymph node positive, axillary lymph node dissection (ALND), post-menopausal endocrine treatment), and health behavioral factors (smoking ≥ 10 cigarettes/day, obesity (BMI ≥ 30 and < 35), comorbidity, poor physical function) were significantly associated with pain at 15 months. Being physically active and moderate alcohol intake (<3 units/day) were negatively associated with pain. At 7–9 years post surgery, only ALND (OR:1.41, p = 0.03), post-menopausal endocrine treatment (OR:1.62, p = 0.01), poorer physical function (ORs:2.00–2.40, p = 0.003), and weight training (h/week) at 15 months (OR:1.10, p = 0.008) were significant predictors of pain when adjusting for age and pain 15 months post surgery. No socio-demographic predictors remained statistically significant. Younger age, lower socio-economic status, more invasive surgery, endocrine treatment, and adverse health behaviors emerged as risk factors for persistent pain. The influence of risk factors changed over time, suggesting a complex course of pain development and maintenance.
Literatur
1.
Zurück zum Zitat Andersen KG, Kehlet H (2011) Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain 12(7):725–746CrossRefPubMed Andersen KG, Kehlet H (2011) Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain 12(7):725–746CrossRefPubMed
2.
Zurück zum Zitat Kehlet Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367:1625–1628CrossRef Kehlet Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367:1625–1628CrossRef
3.
Zurück zum Zitat Gärtner R, Nielsen J, Ewertz M et al (2009) Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 302(18):1985–1992CrossRefPubMed Gärtner R, Nielsen J, Ewertz M et al (2009) Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 302(18):1985–1992CrossRefPubMed
4.
Zurück zum Zitat Peuckmann V, Ekholm O, Rasmussen NK et al (2009) Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain 13(5):478–485CrossRefPubMed Peuckmann V, Ekholm O, Rasmussen NK et al (2009) Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain 13(5):478–485CrossRefPubMed
5.
Zurück zum Zitat Anderson KO, Reyes-Gibby CC (2013) Biopsychosocial approach to persistent post-mastectomy pain: what can we conclude? Pain 154(5):623–624CrossRefPubMed Anderson KO, Reyes-Gibby CC (2013) Biopsychosocial approach to persistent post-mastectomy pain: what can we conclude? Pain 154(5):623–624CrossRefPubMed
6.
Zurück zum Zitat Poleschuk EL, Katz J, Andrus CH et al (2006) Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain 7(9):626–634CrossRef Poleschuk EL, Katz J, Andrus CH et al (2006) Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain 7(9):626–634CrossRef
7.
Zurück zum Zitat Fernández-Lao C, Cantarero-Villanueva I, Fernández-de-las-Peñas C et al (2011) Widespread mechanical pain hypersensitivity as a sign of central sensitization after breast cancer surgery: comparison between mastectomy and lumpectomy. Pain Med 12(1):72–78CrossRefPubMed Fernández-Lao C, Cantarero-Villanueva I, Fernández-de-las-Peñas C et al (2011) Widespread mechanical pain hypersensitivity as a sign of central sensitization after breast cancer surgery: comparison between mastectomy and lumpectomy. Pain Med 12(1):72–78CrossRefPubMed
8.
Zurück zum Zitat Bianco PD, Zavagno G, Burelli P et al (2008) Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 34(5):508–513CrossRefPubMed Bianco PD, Zavagno G, Burelli P et al (2008) Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 34(5):508–513CrossRefPubMed
9.
Zurück zum Zitat Steegers MA, Wolters B, Evers AW et al (2008) Effect of axillary lymph node dissection on prevalence and intensity of chronic and phantom pain after breast cancer surgery. J Pain 9(9):813–822CrossRefPubMed Steegers MA, Wolters B, Evers AW et al (2008) Effect of axillary lymph node dissection on prevalence and intensity of chronic and phantom pain after breast cancer surgery. J Pain 9(9):813–822CrossRefPubMed
10.
Zurück zum Zitat Jung BF, Ahrendt GM, Oaklander AL et al (2003) Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain 104:1–13CrossRefPubMed Jung BF, Ahrendt GM, Oaklander AL et al (2003) Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain 104:1–13CrossRefPubMed
11.
Zurück zum Zitat Levy MH, Chwistek M, Mehta R (2008) Management of chronic pain in cancer survivors. Cancer J 14(6):401–409CrossRefPubMed Levy MH, Chwistek M, Mehta R (2008) Management of chronic pain in cancer survivors. Cancer J 14(6):401–409CrossRefPubMed
12.
Zurück zum Zitat Mejdahl M, Andersen K, Gärtner R et al (2013) Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study. BMJ 1865(April):1–14 Mejdahl M, Andersen K, Gärtner R et al (2013) Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study. BMJ 1865(April):1–14
13.
Zurück zum Zitat Noeres D, Park-Simon T-W, Grabow J et al (2013) Return to work after treatment for primary breast cancer over a 6-year period: results from a prospective study comparing patients with the general population. Support Care Cancer 21(7):1901–1909CrossRefPubMed Noeres D, Park-Simon T-W, Grabow J et al (2013) Return to work after treatment for primary breast cancer over a 6-year period: results from a prospective study comparing patients with the general population. Support Care Cancer 21(7):1901–1909CrossRefPubMed
14.
Zurück zum Zitat Miaskowski C, Cooper B, Paul SM et al (2012) Identification of patient subgroups and risk factors for persistent breast pain following breast cancer surgery. J Pain 13(12):1172–1187PubMedCentralCrossRefPubMed Miaskowski C, Cooper B, Paul SM et al (2012) Identification of patient subgroups and risk factors for persistent breast pain following breast cancer surgery. J Pain 13(12):1172–1187PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Eaker S, Wigertz A, Lambert PC, Bergkvist L et al (2011) Breast cancer, sickness absence, income and marital status. A study on life situation 1 year prior diagnosis compared to 3 and 5 years after diagnosis. PLoS One 6(3):e18040PubMedCentralCrossRefPubMed Eaker S, Wigertz A, Lambert PC, Bergkvist L et al (2011) Breast cancer, sickness absence, income and marital status. A study on life situation 1 year prior diagnosis compared to 3 and 5 years after diagnosis. PLoS One 6(3):e18040PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Rief W, Barwell WA, Dimsdale JE et al (2011) Long-term course of pain in breast cancer survivors: a 4-year longitudinal study. Breast Cancer Res Treat 130:579–586PubMedCentralCrossRefPubMed Rief W, Barwell WA, Dimsdale JE et al (2011) Long-term course of pain in breast cancer survivors: a 4-year longitudinal study. Breast Cancer Res Treat 130:579–586PubMedCentralCrossRefPubMed
17.
18.
Zurück zum Zitat Ditre JW, Brandon TH, Zale EL et al (2011) Pain, nicotine, and smoking: research findings and mechanistic considerations. Psychol Bull 137(6):1065–1093PubMedCentralCrossRefPubMed Ditre JW, Brandon TH, Zale EL et al (2011) Pain, nicotine, and smoking: research findings and mechanistic considerations. Psychol Bull 137(6):1065–1093PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Patterson AL, Gritzner S, Resnick MP et al (2012) Smoking cigarettes as a coping strategy for chronic pain is associated with greater pain intensity and poorer pain-related function. J Pain 13(3):285–292PubMedCentralCrossRefPubMed Patterson AL, Gritzner S, Resnick MP et al (2012) Smoking cigarettes as a coping strategy for chronic pain is associated with greater pain intensity and poorer pain-related function. J Pain 13(3):285–292PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Sipilä R, Estlander AM, Tasmuth T, Kataja M et al (2012) Development of a screening instrument for risk factors of persistent pain after breast cancer surgery. Br J Cancer 107(9):1459–1466PubMedCentralCrossRefPubMed Sipilä R, Estlander AM, Tasmuth T, Kataja M et al (2012) Development of a screening instrument for risk factors of persistent pain after breast cancer surgery. Br J Cancer 107(9):1459–1466PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Forsythe LP, Alfano CM, George SM et al (2013) Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behavior. Breast Cancer Res Treat 137(2):617–630PubMedCentralCrossRefPubMed Forsythe LP, Alfano CM, George SM et al (2013) Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behavior. Breast Cancer Res Treat 137(2):617–630PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Caffo O, Amichetti M, Ferro A et al (2003) Pain and quality of life after surgery for breast cancer. Breast Cancer Res Treat 80(1):39–48CrossRefPubMed Caffo O, Amichetti M, Ferro A et al (2003) Pain and quality of life after surgery for breast cancer. Breast Cancer Res Treat 80(1):39–48CrossRefPubMed
23.
Zurück zum Zitat MacDonald L, Bruce J, Scott NW et al (2005) Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 92:225–230PubMedCentralPubMed MacDonald L, Bruce J, Scott NW et al (2005) Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 92:225–230PubMedCentralPubMed
24.
Zurück zum Zitat Jim HSL, Small BJ, Minton S et al (2012) History of major depressive disorder prospectively predicts worse quality of life in women with breast cancer. Ann Behav Med 43(3):402–408PubMedCentralCrossRefPubMed Jim HSL, Small BJ, Minton S et al (2012) History of major depressive disorder prospectively predicts worse quality of life in women with breast cancer. Ann Behav Med 43(3):402–408PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Bair MJ, Robinson RL, Katon W et al (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163(20):2433–2445CrossRefPubMed Bair MJ, Robinson RL, Katon W et al (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163(20):2433–2445CrossRefPubMed
26.
Zurück zum Zitat Christensen S, Zachariae R, Jensen AB et al (2009) Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat 113(2):339–355CrossRefPubMed Christensen S, Zachariae R, Jensen AB et al (2009) Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat 113(2):339–355CrossRefPubMed
27.
Zurück zum Zitat Singletary S (2002) Revision of the American joint committee on cancer staging system for breast cancer. J Clin Oncol 20(17):3628–3636CrossRefPubMed Singletary S (2002) Revision of the American joint committee on cancer staging system for breast cancer. J Clin Oncol 20(17):3628–3636CrossRefPubMed
28.
Zurück zum Zitat Rostgaard K, Holst H, Mouridsen HT et al (2000) Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control 11(7):669–674CrossRefPubMed Rostgaard K, Holst H, Mouridsen HT et al (2000) Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control 11(7):669–674CrossRefPubMed
29.
Zurück zum Zitat Møller S, Jensen M, Ejlertsen B et al (2008) The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 47(4):506–524CrossRefPubMed Møller S, Jensen M, Ejlertsen B et al (2008) The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 47(4):506–524CrossRefPubMed
30.
31.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed
32.
Zurück zum Zitat Extermann M (2000) Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 35(3):181–200CrossRefPubMed Extermann M (2000) Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 35(3):181–200CrossRefPubMed
33.
Zurück zum Zitat World Health Organization (WHO) (2000) Obesity. Preventing and managing the global endemic. Geneva: Technial Report Series no 894 World Health Organization (WHO) (2000) Obesity. Preventing and managing the global endemic. Geneva: Technial Report Series no 894
34.
Zurück zum Zitat Washburn RA, Smith KW, Jette AM et al (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46(2):153–162CrossRefPubMed Washburn RA, Smith KW, Jette AM et al (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46(2):153–162CrossRefPubMed
35.
Zurück zum Zitat Ware JE, Sherbourne CD (1992) The MOS 36-Item short-form health survey (SF-36). Med Care 30(6):473–483CrossRefPubMed Ware JE, Sherbourne CD (1992) The MOS 36-Item short-form health survey (SF-36). Med Care 30(6):473–483CrossRefPubMed
36.
Zurück zum Zitat Ashing-Giwa KT, Lim J (2009) Examining the impact of socioeconomic status and socioecologic stress on physical and mental health quality of life among breast cancer survivors. Oncology 36(1):79–88 Ashing-Giwa KT, Lim J (2009) Examining the impact of socioeconomic status and socioecologic stress on physical and mental health quality of life among breast cancer survivors. Oncology 36(1):79–88
37.
Zurück zum Zitat Jakesz R, Jonat W, Gnant M et al (2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years’ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366(9484):455–462CrossRefPubMed Jakesz R, Jonat W, Gnant M et al (2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years’ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366(9484):455–462CrossRefPubMed
38.
Zurück zum Zitat Presant CA, Bosserman L, Young T et al (2007) Aromatase inhibitor-associated arthralgia and/or bone pain: frequency and characterization in non-clinical trial patients. Clin Breast Cancer 7(10):775–778CrossRefPubMed Presant CA, Bosserman L, Young T et al (2007) Aromatase inhibitor-associated arthralgia and/or bone pain: frequency and characterization in non-clinical trial patients. Clin Breast Cancer 7(10):775–778CrossRefPubMed
39.
Zurück zum Zitat Crew KD, Greenlee H, Capodice J et al (2007) Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 25(25):3877–3883CrossRefPubMed Crew KD, Greenlee H, Capodice J et al (2007) Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 25(25):3877–3883CrossRefPubMed
40.
Zurück zum Zitat Alfano CM, Smith AW, Irwin ML et al (2007) Physical activity, long-term symptoms, and physical health-related quality of life among breast cancer survivors: a prospective analysis. J Cancer Surviv 1(2):116–128PubMedCentralCrossRefPubMed Alfano CM, Smith AW, Irwin ML et al (2007) Physical activity, long-term symptoms, and physical health-related quality of life among breast cancer survivors: a prospective analysis. J Cancer Surviv 1(2):116–128PubMedCentralCrossRefPubMed
41.
Zurück zum Zitat Kwon JH (2014) Overcoming barriers in cancer pain management. J Clin Oncol 32(16):1727–1733CrossRefPubMed Kwon JH (2014) Overcoming barriers in cancer pain management. J Clin Oncol 32(16):1727–1733CrossRefPubMed
42.
Zurück zum Zitat Deandrea S, Montanari M, Moja L et al (2008) Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 19(12):1985–1991PubMedCentralCrossRefPubMed Deandrea S, Montanari M, Moja L et al (2008) Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 19(12):1985–1991PubMedCentralCrossRefPubMed
43.
Zurück zum Zitat Melzack R (1975) The McGill pain questionnaire: major properties and scoring methods. Pain 1(1):277–299CrossRefPubMed Melzack R (1975) The McGill pain questionnaire: major properties and scoring methods. Pain 1(1):277–299CrossRefPubMed
Metadaten
Titel
Socio-demographic, treatment-related, and health behavioral predictors of persistent pain 15 months and 7–9 years after surgery: a nationwide prospective study of women treated for primary breast cancer
verfasst von
M Johannsen
S Christensen
R Zachariae
AB Jensen
Publikationsdatum
01.08.2015
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2015
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3497-x

Weitere Artikel der Ausgabe 3/2015

Breast Cancer Research and Treatment 3/2015 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.